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Abstract Objective: To measure
the effect of intense neuromuscular
blockade (NMB) on oxygen con-
sumption (VO2) in deeply sedated and
mechanically ventilated children on
the first day after complex congenital
cardiac surgery. Design: Prospec-
tive clinical interventional study.
Setting: Pediatric intensive care unit
of an university medical centre.
Measurements and results: Nine
mechanically ventilated and sedated
children (weight 2.8–8.7 kg) were
included. All children were treated
with vasoactive drugs. The level of
sedation was quantified using the
comfort score, Ramsay score and
bispectral index (BIS). The intensity of
NMB was quantified using acceler-
omyography and VO2 was measured
using indirect calorimetry. Analgo-
sedation using various intravenous
agents was targeted at a deep level
(comfort score \ 18, BIS \ 60 and
Ramsay score [ 4). NMB was
achieved by intravenous administra-
tion of rocuronium. All measurements
were conducted before, during and
after recovery from a period of intense
NMB. Baseline values were VO2
6.1 ml/(kg min) (SD 1.3), comfort
score 13 (SD 0.7), BIS 42.5 (SD 14.2),
mean blood pressure 54.0 mmHg (SD
10.5), mean heart rate 129.9 bpm (SD
28.9) and mean core temperature
36.7C (SD 0.5). There were no sig-
nificant differences in VO2 or other
parameters between baseline, during
NMB and the recovery phase.
Conclusion: Neuromuscular block-
ing agents do not reduce oxygen
consumption in deeply sedated and
mechanically ventilated children after
congenital cardiac surgery.
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PEEP Positive end expiratory
pressure (cmH2O)
TOF Train-of-four (ratio)
T1 First response in the
train-of-four (%)
TCNT TOF count
FiO2 Inspiratory oxygen fraction
PA Pulmonary atresia
PDA Patent ductusarteriosus
TPGV Transposition great vessels
Fallot Tetralogy of Fallot
AVSD Atrioventricularseptal defect
VSD Ventricular septal defect
MAPCA Major aorto-pulmonary
collateral arteries
LOS Length of stay
BIS Bispectral index
SaO2 Arterial oxygen saturation
(%)
MAP Mean arterial pressure
(mmHg)
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Introduction
Following complex congenital cardiac surgery, a certain
number of patients suffer from a low cardiac output syn-
drome leading to a distorted balance between oxygen
delivery (DO2) and oxygen consumption (VO2) [1].
Besides sedation and mechanical ventilation, the use of
neuromuscular blocking agents has been recommended in
order to decrease VO2 [2].
To date, studies investigating the effect of neuro-
muscular blockade (NMB) on oxygen consumption show
conflicting results, which may be explained by differences
in study design [3–6].
We measured the effect of intense neuromuscular
blockade on oxygen consumption in deeply sedated and
mechanically ventilated children on the first day after
complex congenital cardiac surgery.
Methods
This study was conducted in accordance with the Dutch
national legislation concerning biomedical studies in children
and was approved by the national and local ethics committees
concerning medical research in humans. Oral and written
informed consent was obtained from both parents.
We included children below 2 years of age on the first
postoperative day following complex congenital cardiac
surgery necessitating sedation and mechanical ventilation.
Additional inclusion criteria were a body temperature
between 36.0 and 38.0C, FiO2 less than 0.6 and air leak
less than 10%. Exclusion criteria were severe renal
insufficiency, allergy to rocuronium, and the use of NMB
on the same day prior to the study. Hemodynamic and
respiratory monitoring was routinely performed using a
HP Merlin monitoring system (HP, Irvine, USA). A rap-
idly changing blood pressure and/or heart rate were
additional exclusion criteria.
All patients received analgo-sedation at the discretion
of the treating physician (Table 1). Also, all children
received inotropic agents consisting of a combination
of dobutamine (mean dose 4.9 lg/kg/min) and/or nor-
epinephrine (mean dose 0.4 lg/kg/min) combined with
either enoximone of milrinone. Nutritional demands were
met using either enteral feeding or intravenous dextrose as
judged clinically necessary.
Oxygen consumption and carbon dioxide production
were measured using the Deltatrac II metabolic monitor
(GE healthcare, Chalfont St Giles, UK) as described
previously [7]. This device provides a minute to minute
VO2 value.
The bispectral index monitor (BIS, Aspect Medical
Systems, USA) is based upon a one channel EEG
recording at the frontal location. The device provides a
value between 0 and 100. A level of 100 equals a fully
awake state, while a level between 40 and 60 reflect deep
sedation or anesthesia. In children the BIS value corre-
lates well with the level of sedation [8]. For clinical
evaluation of the level of sedation the comfort score (CS)
was used which has been described elsewhere [9, 10]. A
score below 17 points reflects deep sedation. Although not
validated in children we also determined the Ramsay
Score (RS) [11]. The sedation scores were always deter-
mined by one author (JL) at the beginning, half-way and
at the end of a recording period.
The intensity of NMB was guided by acceleromyo-
graphic recording of the thumb adduction following train-
of-four stimulation (TOF) of the ulnar nerve with a 1-min
interval (TOF-watch, Organon, Boxtel, the Netherlands).
This device has been validated in small children [12, 13].

















1 7 4.9 PA, VSD, MAPCA’s 4 1.4 1.8 0.40 mf, a, m, p, l
2 2 3 PDA, VSD 11 0.8 33.8 0.40 mf, a, m, p
3 17 8.7 TPGV ? situs inversus 13 16.2 5.7 0.35 mf, a, m, p, l
4 6.5 7 Fallot ? MAPCA’s 14 4.8 5.9 0.60 mf, a, m, p
5 8 5.3 Fallot 7 2.3 5.9 0.60 mf, a, m, p, k
6 0.5 2.8 AVSD 18 4.6 8.9 0.31 mf, a, m
7 0.1 3 Hypoplastic right ventricle 4 3.0 8.9 0.21 mf, a, m, p
8 0.25 3.3 Intracardiac tumor 4 13.7 6.1 0.45 mf, a, m
9 6 6.4 VSD 10 0.8 5.9 0.60 mf, a, m, p, k
Mean value 5.3 4.9 9.4 5.2 9.2 0.40
PA pulmonary atresia, MAPCA major aorto-pulmonary collateral
arteries, PDA patent ductusarteriosus, TPGV transposition great
vessels, Fallot fallot tetrology, AVSD atrioventricularseptal defect,
VSD ventricular septal defect, LOS length of stay at the PICU, PIM
pediatric index of mortality, PRISMII pediatric risk of mortality
version II, mf morphine, a acetaminophen, m midazolam, p pro-
pofol, l levopromazine, k s-ketamine
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A TOF count (TCNT) of zero was considered intense
NMB. A TOF ratio [ 0.8 and the first response in the
train-of-four (T1) [ 80% indicated sufficient clinical
recovery from NMB.
We also collected PIM and PRISMII scores reflecting
severity of illness [14, 15]. Furthermore, we collected
data concerning length of stay (LOS), diagnosis, weight,
height, and age. Mean blood pressure, heart rate, and core
temperature were continuously measured.
At the start of the experiment, care was taken to
provide a deep level of sedation with a CS less than or
equal to 17, a RS higher than 4 and a BIS value less than
60. When this level of sedation was reached (but before
NMB was instituted) a baseline registration was per-
formed. Hereafter intense NMB was achieved by
administering rocuronium in a dose of 0.3 mg/kg. If the
TCNT did not decrease to 0 additional doses of rocuro-
nium 0.15 mg/kg were given until the required TCNT
was reached. At that point the registration of the NMB
phase was started. During this phase, additional rocuro-
nium (0.15 mg/kg) was administered if the TCNT value
increased[0. After recording of the NMB phase time was
taken to let the muscle relaxant ware off. When the TOF
value exceeded 0.8 and T1 [ 80% recording of the
recovery phase was performed.
A registration period in which all variables were col-
lected lasted 20 min. The mean value of these 20 min was
taken for further calculation.
The coefficient of variation of the VO2 measurement
was calculated by dividing the standard deviation of
measurements with 1-min interval by the mean value of
the 20-min episode. Sample size calculation was per-
formed using an expected variation of VO2 measurement
of 7%, a clinically significant change in VO2 of at least
5%, a power of 80% and P value of 0.05. This resulted in
a sample size of 13. Potential differences between various
parameters during baseline, NMB and recovery were
analyzed using ANOVA. Statistical calculations were
performed using MedCalc version 9 (MedCalc Software,
Mariakerke, Belgium).
Results
The coefficient of variation of the VO2 measurements was
3.7% at baseline, 3.3% during NMB and 3.5% after
recovery from NMB (mean 3.5%). Because the coeffi-
cient of variation was lower than anticipated (3.6 vs. 7%),
we stopped the study after the inclusion of nine patients
while maintaining the previously mentioned power.
Patient details are depicted in Table 1. The mean dose
of rocuronium needed to achieve intense NMB was
0.7 mg/kg (range 0.3–1.2 mg/kg).
Figure 1 shows the individual changes in VO2 for the
nine patients during the experiment. Table 2 shows the
mean values for several parameters before, during, and
after neuromuscular blockade. Using ANOVA no changes
in VO2 or any of the other parameters were detected
between baseline, during neuromuscular blockade, and
the recovery phase except for intensity of NMB.
Discussion
This study shows that neuromuscular blocking agents do
not reduce metabolic needs in deeply sedated and
mechanically ventilated children after cardiac surgery.
In critically ill children one other study also observed
a lack of difference between children with or without
NMB [16]. However, most studies found a reduction in
VO2 after application of NMB [3–6, 17], although in some
studies the effect was smaller or absent in patients without
spontaneous movements before NMB was instituted [6].
One study in deeply sedated adults found similar results
compared to our study [18]. We believe the level of
sedation explains these differences. All children in our
study were on controlled mechanical ventilation and had a
documented deep level of sedation. Since NMB only
affects skeletal muscle activity it seems logical to assume
that, when muscle activity is already very low, a further
reduction in VO2 is not to be expected.
We made several precautions to optimize the validity
of the recorded data. All measurements were recorded
automatically; sedation scores were recorded by the same
person and were supplemented by a measured BIS value.
Fig. 1 Individual course of oxygen consumption during the
baseline, NMB and recovery phase (n = 9)
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Also we observed a small variation in the VO2 measure-
ment. Furthermore the intensity of the neuromuscular
blockade was recorded using an established technique
validated in (young) children. Using this technique we
could actually demonstrate an intense level of NMB
during the study and on the other hand a sufficient level of
recovery at the end of the study.
The study is limited by several factors. With oxygen
fractions in excess of 0.4 the accuracy of VO2 measure-
ment may decrease [7]. Although three children in our
study were ventilated with a FiO2 in excess of 0.4
(Table 1) the goal of this study was to detect changes in
VO2 within a relatively small time interval and because
each patient acted as his or her own control we consider
this to be of minor influence. The reliability of BIS and
sedation scores might be questionable. It is therefore
possible that several children reached a sedation level
which was equivalent to an anesthesia level. Caution is
advised to extrapolate these results to other critically ill
children, for example, with sepsis, trauma, or respiratory
failure. Furthermore in our study only one child had a
SaO2 below 90% and our results may therefore not apply
to children with a severe cyanosis. Lastly we only mea-
sured the effect of NMB on the first postoperative day.
Results could differ when NMB is instituted in a later
clinical phase.
While the level of sedation seems to be very impor-
tant in the reduction of VO2, the use of high dose
sedatives seems attractive with the need for a reduction in
VO2. However these agents are associated with many
side effects or complications [19] and might even reduce
cardiac output. On the other hand, prolonged NMB is
also associated with various possible side effects. The
most feared complication is the critical illness neuro-
muscular disease [20].
Conclusion
Neuromuscular blocking agents do not reduce oxygen
consumption and therefore do not reduce energy expen-
diture in well-sedated children following complex
congenital cardiac surgery.
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